5 Heart Disease Clinical Trials in Mobile, AL (2026)

Q: How do I join a clinical trial in Mobile?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you.

Recruiting Heart Disease Studies in Mobile

NCT07000357Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in ...

Mobile, ALPHASE315,100 participantsAstraZeneca

View Study Details

NCT07037433Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morb...

Mobile, ALPHASE312,800 participantsAmgen

View Study Details

NCT07136012Recruiting

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization...

Mobile, ALPHASE311,000 participantsAmgen

View Study Details

NCT07517263Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

This open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301)....

Mobile, ALPHASE35,700 participantsNovartis Pharmaceuticals

View Study Details

NCT07232069Recruiting

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if screening and early treatment of mild hea...

Mobile, ALPHASE31,500 participantsDuke University

View Study Details

About Heart Disease Clinical Trials in Mobile

Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.

There are currently 5 heart disease clinical trials recruiting participants in Mobile, AL. These studies are seeking a combined 46,100 participants. Research is being sponsored by AstraZeneca, Amgen, Novartis Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Disease Clinical Trials in Mobile — FAQ

Are there heart disease clinical trials in Mobile?

Yes, there are 5 heart disease clinical trials currently recruiting in Mobile, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mobile?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.

Are clinical trials in Mobile free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.

What heart disease treatments are being tested?

The 5 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.

Data updated July 21, 2026 from ClinicalTrials.gov